S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.68 (-0.31%)
AAPL   137.59 (+0.17%)
MSFT   252.56 (-0.23%)
FB   193.54 (+1.18%)
GOOGL   2,178.16 (-1.34%)
AMZN   2,151.82 (+0.25%)
TSLA   663.90 (-6.42%)
NVDA   166.94 (-2.51%)
BABA   86.79 (-1.03%)
NIO   16.44 (-1.32%)
AMD   93.50 (-3.28%)
CGC   5.52 (-5.96%)
MU   68.90 (-0.72%)
T   20.40 (+0.94%)
GE   75.25 (-0.65%)
F   12.50 (-2.72%)
DIS   102.42 (-0.70%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.54 (-0.91%)
NFLX   186.35 (+1.56%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.68 (-0.31%)
AAPL   137.59 (+0.17%)
MSFT   252.56 (-0.23%)
FB   193.54 (+1.18%)
GOOGL   2,178.16 (-1.34%)
AMZN   2,151.82 (+0.25%)
TSLA   663.90 (-6.42%)
NVDA   166.94 (-2.51%)
BABA   86.79 (-1.03%)
NIO   16.44 (-1.32%)
AMD   93.50 (-3.28%)
CGC   5.52 (-5.96%)
MU   68.90 (-0.72%)
T   20.40 (+0.94%)
GE   75.25 (-0.65%)
F   12.50 (-2.72%)
DIS   102.42 (-0.70%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.54 (-0.91%)
NFLX   186.35 (+1.56%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.68 (-0.31%)
AAPL   137.59 (+0.17%)
MSFT   252.56 (-0.23%)
FB   193.54 (+1.18%)
GOOGL   2,178.16 (-1.34%)
AMZN   2,151.82 (+0.25%)
TSLA   663.90 (-6.42%)
NVDA   166.94 (-2.51%)
BABA   86.79 (-1.03%)
NIO   16.44 (-1.32%)
AMD   93.50 (-3.28%)
CGC   5.52 (-5.96%)
MU   68.90 (-0.72%)
T   20.40 (+0.94%)
GE   75.25 (-0.65%)
F   12.50 (-2.72%)
DIS   102.42 (-0.70%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.54 (-0.91%)
NFLX   186.35 (+1.56%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.68 (-0.31%)
AAPL   137.59 (+0.17%)
MSFT   252.56 (-0.23%)
FB   193.54 (+1.18%)
GOOGL   2,178.16 (-1.34%)
AMZN   2,151.82 (+0.25%)
TSLA   663.90 (-6.42%)
NVDA   166.94 (-2.51%)
BABA   86.79 (-1.03%)
NIO   16.44 (-1.32%)
AMD   93.50 (-3.28%)
CGC   5.52 (-5.96%)
MU   68.90 (-0.72%)
T   20.40 (+0.94%)
GE   75.25 (-0.65%)
F   12.50 (-2.72%)
DIS   102.42 (-0.70%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.54 (-0.91%)
NFLX   186.35 (+1.56%)
NASDAQ:MLAB

Mesa Laboratories (MLAB) Stock Forecast, Price & News

$212.06
-0.11 (-0.05%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$209.54
$214.89
50-Day Range
$212.17
$267.29
52-Week Range
$209.54
$333.42
Volume
26,602 shs
Average Volume
26,252 shs
Market Capitalization
$1.11 billion
P/E Ratio
148.29
Dividend Yield
0.30%
Beta
0.54
30 days | 90 days | 365 days | Advanced Chart
Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Mesa Laboratories logo

About Mesa Laboratories

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Process control instruments
Sub-Industry
Electronic Equipment & Instruments
Sector
Medical
Current Symbol
NASDAQ:MLAB
CUSIP
59064R10
Employees
506
Year Founded
N/A

Sales & Book Value

Annual Sales
$133.94 million
Cash Flow
$9.60 per share
Book Value
$79.16 per share

Profitability

Net Income
$3.27 million
Pretax Margin
5.21%

Debt

Price-To-Earnings

Miscellaneous

Free Float
4,978,000
Market Cap
$1.11 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
5/31/2021
Ex-Dividend for 3/15 Dividend
2/25/2022
Dividend Payable
3/15/2022
Today
5/20/2022
Ex-Dividend for 6/15 Dividend
5/27/2022
Next Earnings (Estimated)
6/07/2022
Dividend Payable
6/15/2022
Fiscal Year End
3/31/2023

MarketRank

Overall MarketRank

2.09 out of 5 stars

Medical Sector

489th out of 1,420 stocks

Process Control Instruments Industry

9th out of 17 stocks

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 1.7Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -













Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release its next quarterly earnings announcement on Tuesday, June 7th 2022.
View our earnings forecast for Mesa Laboratories
.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its quarterly earnings data on Monday, May, 31st. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.91 by $0.17. The medical instruments supplier earned $37.96 million during the quarter, compared to analysts' expectations of $34.92 million. Mesa Laboratories had a trailing twelve-month return on equity of 6.23% and a net margin of 4.64%.
View Mesa Laboratories' earnings history
.

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories announced a quarterly dividend on Wednesday, April 6th. Shareholders of record on Tuesday, May 31st will be given a dividend of $0.16 per share on Wednesday, June 15th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.30%. The ex-dividend date of this dividend is Friday, May 27th.
View Mesa Laboratories' dividend history
.

Is Mesa Laboratories a good dividend stock?

Mesa Laboratories pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.30%. The dividend payout ratio of Mesa Laboratories is 44.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 9.12% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.
View Mesa Laboratories' dividend history.

Who are Mesa Laboratories' key executives?
Mesa Laboratories' management team includes the following people:
What is Gary Owens' approval rating as Mesa Laboratories' CEO?

5 employees have rated Mesa Laboratories CEO Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among Mesa Laboratories' employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Mesa Laboratories' key competitors?
What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX).

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (17.63%), Conestoga Capital Advisors LLC (9.98%), Royce & Associates LP (6.79%), Vanguard Group Inc. (6.50%), Invesco Ltd. (5.29%) and State Street Corp (3.76%). Company insiders that own Mesa Laboratories stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan and John Sakys.
View institutional ownership trends for Mesa Laboratories
.

Which institutional investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including Daiwa Securities Group Inc., Zurcher Kantonalbank Zurich Cantonalbank , Prudential Financial Inc., Bank of New York Mellon Corp, Rice Hall James & Associates LLC, BNP Paribas Arbitrage SA, UBS Group AG, and Renaissance Technologies LLC. Company insiders that have sold Mesa Laboratories company stock in the last year include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, and John Sakys.
View insider buying and selling activity for Mesa Laboratories
or view top insider-selling stocks.

Which institutional investors are buying Mesa Laboratories stock?

MLAB stock was acquired by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Royce & Associates LP, Granahan Investment Management LLC, Conestoga Capital Advisors LLC, State Street Corp, Raymond James & Associates, Vanguard Group Inc., and Moody Aldrich Partners LLC.
View insider buying and selling activity for Mesa Laboratories
or or view top insider-buying stocks.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $212.06.

How much money does Mesa Laboratories make?

Mesa Laboratories has a market capitalization of $1.11 billion and generates $133.94 million in revenue each year. The medical instruments supplier earns $3.27 million in net income (profit) each year or $1.43 on an earnings per share basis.

How many employees does Mesa Laboratories have?

Mesa Laboratories employs 506 workers across the globe.

What is Mesa Laboratories' official website?

The official website for Mesa Laboratories is www.mesalabs.com.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at (303) 987-8000, via email at [email protected], or via fax at 303-987-8989.

This page was last updated on 5/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.